Coldstream Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.1M | Buy |
74,217
+727
| +1% | +$161K | 0.2% | 66 |
|
|
2025
Q4 | $16.8M | Buy |
73,490
+1,980
| +3% | +$451K | 0.22% | 66 |
|
|
2025
Q3 | $16.6M | Sell |
71,510
-1,322
| -2% | -$269K | 0.22% | 64 |
|
|
2025
Q2 | $13.5M | Buy |
72,832
+6,227
| +9% | +$1.16M | 0.22% | 70 |
|
|
2025
Q1 | $14M | Buy |
66,605
+1,377
| +2% | +$268K | 0.3% | 56 |
|
|
2024
Q4 | $11.6M | Buy |
65,228
+3,157
| +5% | +$580K | 0.25% | 57 |
|
|
2024
Q3 | $12.2M | Buy |
62,071
+3,405
| +6% | +$635K | 0.26% | 55 |
|
|
2024
Q2 | $10.1M | Buy |
58,666
+602
| +1% | +$99.7K | 0.25% | 56 |
|
|
2024
Q1 | $10.6M | Buy |
58,064
+2,995
| +5% | +$516K | 0.27% | 51 |
|
|
2023
Q4 | $8.53M | Buy |
55,069
+2,248
| +4% | +$328K | 0.24% | 57 |
|
|
2023
Q3 | $7.87M | Buy |
52,821
+1,839
| +4% | +$270K | 0.26% | 59 |
|
|
2023
Q2 | $6.87M | Sell |
50,982
-1,451
| -3% | -$213K | 0.22% | 69 |
|
|
2023
Q1 | $8.36M | Buy |
52,433
+1,222
| +2% | +$187K | 0.28% | 55 |
|
|
2022
Q4 | $8.28M | Buy |
+51,211
| New | +$7.85M | 0.3% | 52 |
|
|
2022
Q2 | $8.51M | Buy |
55,581
+2,244
| +4% | +$343K | 0.33% | 54 |
|
|
2022
Q1 | $8.65M | Sell |
53,337
-2,432
| -4% | -$353K | 0.3% | 53 |
|
|
2021
Q4 | $7.55M | Buy |
55,769
+14,601
| +35% | +$1.72M | 0.24% | 64 |
|
|
2021
Q3 | $3.61M | Sell |
41,168
-411
| -1% | -$47K | 0.17% | 82 |
|
|
2021
Q2 | $4.68M | Buy |
41,579
+824
| +2% | +$92.8K | 0.19% | 83 |
|
|
2021
Q1 | $4.41M | Buy |
40,755
+29,286
| +255% | +$3.13M | 0.26% | 63 |
|
|
2020
Q4 | $1.23M | Sell |
11,469
-26,370
| -70% | -$2.53M | 0.07% | 133 |
|
|
2020
Q3 | $3.31M | Sell |
37,839
-187
| -0.5% | -$17.6K | 0.28% | 59 |
|
|
2020
Q2 | $3.73M | Sell |
38,026
-1,391
| -4% | -$122K | 0.34% | 45 |
|
|
2020
Q1 | $3M | Sell |
39,417
-1,379
| -3% | -$117K | 0.33% | 50 |
|
|
2019
Q4 | $3.61M | Buy |
40,796
+1,508
| +4% | +$125K | 0.3% | 61 |
|
|
2019
Q3 | $2.98M | Sell |
39,288
-164
| -0.4% | -$11.2K | 0.25% | 75 |
|
|
2019
Q2 | $2.87M | Buy |
39,452
+676
| +2% | +$53.1K | 0.24% | 80 |
|
|
2019
Q1 | $3.13M | Sell |
38,776
-1,735
| -4% | -$142K | 0.27% | 72 |
|
|
2018
Q4 | $3.73M | Buy |
40,511
+865
| +2% | +$76.1K | 0.36% | 52 |
|
|
2018
Q3 | $3.75M | Buy |
39,646
+2,302
| +6% | +$218K | 0.34% | 53 |
|
|
2018
Q2 | $3.46M | Buy |
37,344
+506
| +1% | +$49.4K | 0.35% | 48 |
|
|
2018
Q1 | $3.49M | Sell |
36,838
-5,221
| -12% | -$574K | 0.38% | 43 |
|
|
2017
Q4 | $4.07M | Buy |
42,059
+1,690
| +4% | +$159K | 0.44% | 42 |
|
|
2017
Q3 | $3.59M | Buy |
40,369
+4,264
| +12% | +$325K | 0.42% | 47 |
|
|
2017
Q2 | $2.62M | Buy |
36,105
+2,590
| +8% | +$174K | 0.34% | 56 |
|
|
2017
Q1 | $2.18M | Sell |
33,515
-9,169
| -21% | -$576K | 0.3% | 67 |
|
|
2016
Q4 | $2.67M | Buy |
42,684
+1,449
| +4% | +$88.4K | 0.44% | 38 |
|
|
2016
Q3 | $2.6M | Sell |
41,235
-1,486
| -3% | -$96.2K | 0.46% | 36 |
|
|
2016
Q2 | $2.65M | Sell |
42,721
-800
| -2% | -$48.7K | 0.47% | 36 |
|
|
2016
Q1 | $2.49M | Sell |
43,521
-3,841
| -8% | -$214K | 0.45% | 33 |
|
|
2015
Q4 | $2.81M | Buy |
47,362
+718
| +2% | +$41.4K | 0.61% | 24 |
|
|
2015
Q3 | $2.54M | Buy |
46,644
+371
| +0.8% | +$24.1K | 0.68% | 26 |
|
|
2015
Q2 | $3.11M | Sell |
46,273
-654
| -1% | -$42.7K | 0.81% | 20 |
|
|
2015
Q1 | $2.75M | Buy |
46,927
+10,017
| +27% | +$605K | 0.76% | 29 |
|
|
2014
Q4 | $2.42M | Sell |
36,910
-2,827
| -7% | -$178K | 0.67% | 33 |
|
|
2014
Q3 | $2.29M | Buy |
39,737
+699
| +2% | +$38.8K | 0.65% | 33 |
|
|
2014
Q2 | $2.2M | Sell |
39,038
-1,820
| -4% | -$95.5K | 0.65% | 32 |
|
|
2014
Q1 | $2.1M | Buy |
40,858
+599
| +1% | +$30.3K | 0.68% | 34 |
|
|
2013
Q4 | $2.13M | Sell |
40,259
-503
| -1% | -$24.7K | 0.69% | 30 |
|
|
2013
Q3 | $1.82M | Buy |
40,762
+393
| +1% | +$17.4K | 0.6% | 40 |
|
|
2013
Q2 | $1.67M | Buy |
+40,369
| New | +$1.77M | 0.56% | 47 |
|
Other funds holding ABBV
VCM
VPM
Coldstream Capital Management's ABBV Position: Q1 2026 in Review
Coldstream Capital Management increased its AbbVie (ABBV) stake by 0.99% in Q1 2026, buying an estimated $161K and bringing the position to 74,217 shares worth $16.1M. The position accounts for 0.2% of the portfolio, ranked #66.
Coldstream Capital Management first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $16.8M in Q4 2025. 4,090 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Coldstream Capital Management held 74,217 shares of AbbVie worth $16.1M as of Q1 2026.
- Coldstream Capital Management bought 727 AbbVie shares in Q1 2026, an estimated $161K.
- AbbVie made up 0.2% of Coldstream Capital Management's portfolio in Q1 2026, its #66 holding.
- Coldstream Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- Coldstream Capital Management's AbbVie position peaked at $16.8M in Q4 2025.
- 4,090 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.